Central pancreatectomy might be an acceptable surgical procedure for clinical T1 pancreatic body ductal adenocarcinoma: A multicenter retrospective analysis.
Taichi TeraiManabu KawaiYuji KitahataSohei SatoiDaisuke HashimotoMinako NagaiSatoshi NishiwadaTomohisa YamamotoHiroki YamaueMasayuki ShoPublished in: Journal of hepato-biliary-pancreatic sciences (2023)
The clinical outcomes of CP were comparable to or even better than that of conventional pancreatectomy. Our collaborative study suggests that CP may be an acceptable therapeutic option for selected patients with clinical T1 pancreatic body cancer.